Skip to main content
. 2021 Nov 30;12:785153. doi: 10.3389/fgene.2021.785153

FIGURE 3.

FIGURE 3

Mechanisms of resistance from ICI treatment. 1) β2M mutations lead to loss of HLA and antigen-presenting function. 2) Additional inhibitory signals expression. 3) Little tumor-infiltrating lymphocytes present in the tumor microenvironment resulting in nonresponse. 4) Immune suppressive cells in TME. 5) Loss of IFN-γ sensitivity. 6) Formation of low immunogenicity clone under selective pressure.